Compare ADMA Biologics Inc (ADMA) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: ADMA Biologics Inc is far larger — about 4.4× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.
| ADMA | DNA | |
|---|---|---|
Market Cap | $2.22B | $505.73M |
Sector | Health | Health |
52-Week High | $20.38 | $16.14 |
52-Week Low | $7.60 | $5.48 |
Enterprise Value | $2.29B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
